Hankook Tire Delivers Peak Performance at WRC Secto Rally Finland

Consistent tire performance proved decisive in Rally Finland where razor-sharp precision under extreme conditions determined the final outcome Dynapro R213 delivered unwavering grip and stability through demanding gravel stages packed with flat-out straights and repeated jumps The FIA World Rally Championship next heads to Paraguay for its highly anticipated debut from August 28 to 31 JYVÄSKYLÄ, Finland, […]

HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal

HONG KONG, Aug. 4, 2025 /PRNewswire/ — A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped with silver and gold nanorods to facilitate high-performance pollutant degradation and bacteria elimination, with its mobility navigated by the application of magnetic fields. The invention holds potential for broad applications in […]

PSYCHIC FEVER of LDH JAPAN Embarks on Full-fledged European Expansion, Celebrates 3rd Anniversary with Fan Meeting in London, Raising Anticipation for European Live Tour

TOKYO, Aug. 4, 2025 /PRNewswire/ — On July 13, international boy group PSYCHIC FEVER of LDH JAPAN Inc. held their fan meeting, “PSYCHIC FEVER FIRST EUROPE FANMEET,” in London. Celebrating their 3rd debut anniversary with local fans (ForEVER), the event was filled with excitement and cheers from start to finish, leaving a strong impression of […]

OpenWay in 2025 Matrix für Merchant Acquiring Platforms von Datos Insights als „Best-in-Class” anerkannt

BRÜSSEL, 4. August 2025 /PRNewswire/ — OpenWay, ein weltweit führender Anbieter von Zahlungssoftware und Entwickler der digitalen Zahlungssoftware-Plattform Way4, wurde in der 2025 Merchant Acquiring Software Platforms Matrix von Datos Insights als Best-in-Class-Anbieter ausgezeichnet. Das Ranking platziert OpenWay im Marktführer-Quadranten – basierend auf der Stärke seiner Lösungsfähigkeiten, der hohen Kundenzufriedenheit, dem Innovationsgrad und der starken […]

Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Aug. 4, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225) has been approved to initiate by both China’s National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). The trial will evaluate cadonilimab, Akeso’s first-in-class PD-1/CTLA-4 bispecific […]

Alveolus Bio obtient un investissement stratégique de Shilpa Medicare pour faire progresser des thérapies pulmonaires révolutionnaires

Shilpa Medicare intervient en tant qu’investisseur principal, positionnant Alveolus Bio pour les essais cliniques de phase 2 et les premières études chez l’homme CAMBRIDGE, Massachusetts, BIRMINGHAM, Alabama, et RAICHUR, Inde, 4 août 2025 /PRNewswire/ — Alveolus Bio, une société de biotechnologie pionnière dans le développement de médicaments respiratoires, fondée par le Dr Vivek Lal de l’Université […]

Alveolus Bio erhält strategische Investition von Shilpa Medicare zur Entwicklung bahnbrechender Lungentherapeutika

Shilpa Medicare fungiert als Hauptinvestor und positioniert Alveolus Bio für klinische Phase-2-Studien und First-in-Human-Studien CAMBRIDGE, Massachusetts, und BIRMINGHAM, Alabama, USA, und RAICHUR, Indien, 4. August 2025  /PRNewswire/ — Alveolus Bio, ein bahnbrechendes Biotech-Unternehmen für die Entwicklung von Atemwegsmedikamenten, gegründet von Dr. Vivek Lal von der University of Alabama in Birmingham, US-Bundesstaat Alabama, gibt eine strategische […]

OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution

AMSTERDAM, Aug. 4, 2025 /PRNewswire/ — OCI Global (Euronext: OCI), (“OCI,” the “Company”) announces today that it will pay a USD 700 million distribution (USD 3.31 per share) on 5 September 2025 through a mix of capital repayment and extraordinary cash dividend. This distribution is pursuant to the resolutions adopted at OCI’s annual general meeting on […]